celltrion

Temasek trims Celltrion stake despite stock slump

Singapore’s sovereign wealth fund pares down its stake in South Korea's leading biologic drug maker for the second time this year as it continues to restructure its investment portfolio.

October 23, 2018

Volatility takes shine off golden age for Asian follow-ons

Follow-on activity is starting to pick up across Asia, but volatility is making after-market performance difficult to judge for buyers and sellers alike.

April 05, 2018

Temasek cuts stake in Celltrion and affiliate for $1b

Singapore’s sovereign wealth fund continues to fine-tune portfolio as it sells a small chunk of its shareholding in South Korea’s Celltrion and Celltrion Healthcare in overnight block deal.

March 07, 2018

Celltrion Healthcare IPO finally lifts off

The sales arm of drug maker Celltrion kicks off Korea's largest share sale this year hoping to match the success of other recent biopharma deals.

June 26, 2017